Παρακαλώ χρησιμοποιήστε αυτό το αναγνωριστικό για να παραπέμψετε ή να δημιουργήσετε σύνδεσμο προς αυτό το τεκμήριο:
https://hdl.handle.net/10442/19830
| Εξειδίκευση τύπου : | Άρθρο σε επιστημονικό περιοδικό |
| Τίτλος: | Pleurotus eryngii Mushrooms Fermented with Human Fecal Microbiota Protect Intestinal Barrier Integrity: Immune Modulation and Signalling Pathways Counter Deoxycholic Acid-Induced Disruption in Healthy Colonic Tissue |
| Δημιουργός/Συγγραφέας: | Kerezoudi, Evangelia N Zervakis, Georgios I [EL] Πλέτσα, Βασιλική[EN] Pletsa, Vassiliki Kyriacou, Adamantini Brummer, Robert J Rangel, Ignacio |
| Ημερομηνία: | 2025-02-14 |
| Γλώσσα: | Αγγλικά |
| ISSN: | 2072-6643 |
| DOI: | 10.3390/nu17040694 |
| Άλλο: | 40005021 |
| Περίληψη: | Background: This study explores the potential of the Pleurotus eryngii mushroom fermentation supernatant (FS-PEWS) as an intervention for mitigating sodium deoxycholate (SDC)-induced intestinal barrier dysfunction and inflammation. Methods: FS-PEWS was assessed for its protective effects against SDC-induced barrier dysfunction and inflammation using an in vitro Caco-2 cell model and ex vivo colonic biopsies from healthy adult donors, where barrier integrity, permeability, immunomodulation and receptor-mediated pathways were evaluated. Results: In Caco-2 cells, SDC exposure downregulated ZO-1, occludin, and claudin-1 expression, with FS-PEWS restoring ZO-1 and claudin-1 levels while maintaining cell viability. In colonic biopsies from healthy adults, FS-PEWS maintained tissue integrity and selectively mitigated transcellular permeability without affecting paracellular permeability when combined with the stressor. Additionally, FS-PEWS exhibited potent anti-inflammatory effects, reducing pro-inflammatory cytokines, e.g., TNF-α, IL-6, and IL-1β and modulating receptor-mediated pathways, i.e., TLR-4, dectin-1. Conclusions: These results demonstrate the potential of FS-PEWS to sustain intestinal barrier function and modulate immune responses under stress, highlighting its therapeutic potential for managing gut barrier dysfunction and inflammation associated with microbial metabolite-induced disruptions. |
| Τίτλος πηγής δημοσίευσης: | Nutrients |
| Τόμος/Κεφάλαιο: | 17 |
| Τεύχος: | 4 |
| Θεματική Κατηγορία: | [EL] Χημική Βιολογία[EN] Chemical Biology [EL] Ανοσολογία[EN] Immunology [EL] Βιοχημεία[EN] Biochemistry [EL] Ιατρική (Γενικά)[EN] Medicine (General) [EL] Γεωργία[EN] Agriculture |
| Λέξεις-Κλειδιά: | Pleurotus eryngii mushrooms Ussing chamber cytokines deoxycholic bile acid gut barrier signalling pathway |
| Χρηματοδότης: | European Union Greece |
| Χρηματοδοτικό πρόγραμμα: | Competitiveness, Entrepreneurship and Innovation |
| Αναγνωριστικό χρηματοδοτικού προγράμματος: | T1EDK-03404 |
| Κάτοχος πνευματικών δικαιωμάτων: | : © 2025 by the authors. Licensee MDPI, Basel, Switzerland. |
| Όροι και προϋποθέσεις δικαιωμάτων: | This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/ licenses/by/4.0/). |
| Ηλεκτρονική διεύθυνση στον εκδότη (link): | https://doi.org/10.3390/nu17040694 |
| Εμφανίζεται στις συλλογές: | Ινστιτούτο Χημικής Βιολογίας - Επιστημονικό έργο
|